SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-20-004062
Filing Date
2020-03-16
Accepted
2020-03-16 16:58:11
Documents
1
Period of Report
2020-03-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3903
  Complete submission text file 0001493152-20-004062.txt   5302
Mailing Address C/O IMPRIMIS PHARMACEUTICALS, INC 12264 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address
BAUM MARK L (Reporting) CIK: 0001274282 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38738 | Film No.: 20717933

Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Issuer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations